194 related articles for article (PubMed ID: 29211406)
1. Can preoperative neutrophil lymphocyte ratio predict malignancy in patients undergoing partial nephrectomy because of renal mass?
Gorgel SN; Ozer K; Kose O; Dindar AS
Int Braz J Urol; 2018; 44(3):461-466. PubMed ID: 29211406
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil-to-lymphocyte ratio as an independent predictor for survival in patients with localized clear cell renal cell carcinoma after radiofrequency ablation: a propensity score matching analysis.
Chang X; Zhang F; Liu T; Wang W; Guo H
Int Urol Nephrol; 2017 Jun; 49(6):967-974. PubMed ID: 28247169
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of preoperative neutrophil-to-lymphocyte ratio in papillary renal cell carcinoma patients after receiving curative surgery based on a retrospective cohort.
Zhang Z; Yu Y; Zheng J; Zhang M; Niu H
BMC Urol; 2021 Mar; 21(1):43. PubMed ID: 33752642
[TBL] [Abstract][Full Text] [Related]
4. The predictive role of preoperative and postoperative neutrophil-lymphocyte ratio in sarcomatoid renal cell carcinoma.
Mano R; Flynn J; Blum KA; Silagy AW; DiNatale RG; Marcon J; Wang A; Sanchez A; Coleman JA; Russo P; Ostrovnaya I; Hakimi AA
Urol Oncol; 2019 Dec; 37(12):916-923. PubMed ID: 31590969
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of preoperative NLR, dNLR, PLR and CRP in surgical renal cell carcinoma patients.
Hu H; Yao X; Xie X; Wu X; Zheng C; Xia W; Ma S
World J Urol; 2017 Feb; 35(2):261-270. PubMed ID: 27255479
[TBL] [Abstract][Full Text] [Related]
6. Preoperative neutrophil-to-lymphocyte ratio predicts the surgical outcome of Xp11.2 translocation/TFE3 renal cell carcinoma patients.
Agizamhan S; Qu F; Liu N; Sun J; Xu W; Zhang L; Guo H; Gan W
BMC Urol; 2018 Jun; 18(1):60. PubMed ID: 29890986
[TBL] [Abstract][Full Text] [Related]
7. Preoperative Neutrophil-lymphocyte Ratio as a Predictor of Overall Survival in Patients with Localized Renal Cell Carcinoma.
Widz D; Mitura P; Buraczynski P; Plaza P; Bar M; Cabanek M; Nowak G; Ostrowska A; Bar K
Urol J; 2020 Jan; 17(1):30-35. PubMed ID: 31087321
[TBL] [Abstract][Full Text] [Related]
8. Retrospective evaluation of ultrasound-indeterminate renal multilocular cystic masses by using neutrophil-lymphocyte ratio and computed tomography.
Wang H; Gu L; Jia R; Zeng J; Liu X; Zhang D; Wu Y; Luo G; Zhang X
Urol Oncol; 2017 Jan; 35(1):35.e7-35.e14. PubMed ID: 27671994
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil-to-Lymphocyte Ratio Predicts Pathological Renal Sinus Fat Invasion in Renal Cell Carcinomas of ≤7 cm with Presumed Renal Sinus Fat Invasion.
Kim J; Park JS; Heo JE; Elghiaty A; Jang WS; Rha KH; Choi YD; Ham WS
Yonsei Med J; 2019 Nov; 60(11):1021-1027. PubMed ID: 31637883
[TBL] [Abstract][Full Text] [Related]
10. Clinical Significance of Preoperative Neutrophil - to - Lymphocyte Ratio in Renal Cell Carcinoma.
Otunctemur A; Dursun M; Besiroglu H; Ozer K; Horsanali O; Ozbek E
Int Braz J Urol; 2016; 42(4):678-84. PubMed ID: 27564277
[TBL] [Abstract][Full Text] [Related]
11. The Value of Neutrophil to Lymphocyte Ratio in Patients Undergoing Cytoreductive Nephrectomy with Thrombectomy.
Peyton CC; Abel EJ; Chipollini J; Boulware DC; Azizi M; Karam JA; Margulis V; Master VA; Matin SF; Raman JD; Sexton WJ; Wood CG; Spiess PE
Eur Urol Focus; 2020 Jan; 6(1):104-111. PubMed ID: 30206003
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of preoperative neutrophil-to-lymphocyte ratio in localized nonclear cell renal cell carcinoma.
de Martino M; Pantuck AJ; Hofbauer S; Waldert M; Shariat SF; Belldegrun AS; Klatte T
J Urol; 2013 Dec; 190(6):1999-2004. PubMed ID: 23831313
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of preoperative and follow-up neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with non-metastatic clear cell renal cell carcinoma.
Kim TW; Lee JH; Shim KH; Choo SH; Choi JB; Ahn HS; Kim SJ; Kim SI
Investig Clin Urol; 2019 Jan; 60(1):14-20. PubMed ID: 30637356
[TBL] [Abstract][Full Text] [Related]
14. Neutrophil-to-Lymphocyte Ratio in Renal Cell Carcinoma Patients.
Çalışkan S; Sungur M; Kaba S; Özsoy E; Koca O; Öztürk Mİ
Folia Med (Plovdiv); 2018 Nov; 60(4):553-557. PubMed ID: 31188772
[TBL] [Abstract][Full Text] [Related]
15. Preoperative neutrophil-lymphocyte ratio predicts death among patients with localized clear cell renal carcinoma undergoing nephrectomy.
Viers BR; Houston Thompson R; Boorjian SA; Lohse CM; Leibovich BC; Tollefson MK
Urol Oncol; 2014 Nov; 32(8):1277-84. PubMed ID: 25017696
[TBL] [Abstract][Full Text] [Related]
16. The Role of Hematological Parameters in Predicting Fuhrman Grade and Tumor Stage in Renal Cell Carcinoma Patients Undergoing Nephrectomy.
Kisa E; Yucel C; Keskin MZ; Karabicak M; Yalcin MY; Cakmak O; Ilbey YO
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31216752
[No Abstract] [Full Text] [Related]
17. Prognostic value of preoperative combined neutrophil, monocyte, and lymphocyte scores in patients with renal cell carcinoma undergoing laparoscopic nephrectomy: A retrospective study.
Ni J; Yao X; Song W; Zhang H; Zhang H; Wang Y; Zhang Y; Wang G; Wang K; Mao W; Peng B
Cancer Med; 2024 May; 13(9):e7214. PubMed ID: 38686610
[TBL] [Abstract][Full Text] [Related]
18. Pre-treatment neutrophil-to-lymphocyte ratio predicts tumor pathology in newly diagnosed renal tumors.
Viers BR; Thompson RH; Lohse CM; Cheville JC; Leibovich BC; Boorjian SA; Tollefson MK
World J Urol; 2016 Dec; 34(12):1693-1699. PubMed ID: 27052014
[TBL] [Abstract][Full Text] [Related]
19. The prognostic utility of preoperative neutrophil-to-lymphocyte ratio in localized clear cell renal cell carcinoma.
Bazzi WM; Tin AL; Sjoberg DD; Bernstein M; Russo P
Can J Urol; 2016 Feb; 23(1):8151-4. PubMed ID: 26892055
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of the combination of preoperative hemoglobin and albumin levels and lymphocyte and platelet counts (HALP) in patients with renal cell carcinoma after nephrectomy.
Peng D; Zhang CJ; Tang Q; Zhang L; Yang KW; Yu XT; Gong Y; Li XS; He ZS; Zhou LQ
BMC Urol; 2018 Mar; 18(1):20. PubMed ID: 29544476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]